Long-term impact of teprotumumab (Tepezza™) on blood glucose levels – Clinical Thyroidology® for the Public

From Clinical Thyroidology^® for the Public: Teprotumumab (Tepezza™) is a relatively new treatment for the management of thyroid eye disease that has shown excellent responses. One of the side effects of this medication is increased blood glucose levels in patients with and without diabetes. This evaluates a long-term group of patients to quantify the severity and implications of teprotumumab-induced hyperglycemia. Read More…